Inactive Instrument

All News Flying Brands Ltd. London S.E.

Equities

Celadon ships to US; Oxford BioDynamics-Goodbody pact	05-23	AN
IQ-AI subsidiary gets second FDA rare paediatric disease designation	05-20	AN
IQ-AI's Imaging Biometrics Gets Second Rare Disease Designation for Drug Candidate	05-20	MT
Ingenta trades in line; Triple Point Social NAV up	05-17	AN
IQ-AI Unit Delivers Software to Insel Gruppe	05-17	MT
IQ-AI subsidiary gets rare paediatric disease designation FDA	05-10	AN
IQ-AI's Imaging Biometrics Obtains Rare Pediatric Disease Designation for Lead Drug Candidate	05-10	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	05-02	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	04-29	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025	02-26	AQ
IQ-AI's Broker Exercises Option to Buy Shares in Placing	02-26	MT
IQ-AI Plans Share Placing to Advance Oral Anti-tumor Agent Development	02-22	MT
IQ-AI shares sink on discounted placing fundraise	02-22	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	02-09	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	02-09	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	02-02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	02-02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	01-10	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	01-10	MT

No results for this search